Crexont (levodopa/carbidopa extended-release capsule) / Amneal  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Crexont (levodopa/carbidopa extended-release capsule) / Amneal
NCT02271503: A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Completed
2
26
US
CD-LD IR, Sinemet, IPX203 180 mg, CD-LD ER 180 mg, IPX203 270 mg, CD-LD ER 270 mg, Rytary 195 mg, Rytary 145 mg
Impax Laboratories, LLC
Parkinson's Disease
08/16
08/16
NCT03007888: A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

Completed
2
28
US
Sinemet, IR CD-LD Tablets, IPX203, IPX203 ER CD-LD Capsules
Impax Laboratories, LLC
Advanced Parkinson's Disease
08/17
08/17

Download Options